vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and ALLIANCE ENTERTAINMENT HOLDING CORP (AENT). Click either name above to swap in a different company.

ALLIANCE ENTERTAINMENT HOLDING CORP is the larger business by last-quarter revenue ($368.7M vs $268.1M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ALLIANCE ENTERTAINMENT HOLDING CORP runs the higher net margin — 2.5% vs 1.4%, a 1.2% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -6.3%). Over the past eight quarters, ALLIANCE ENTERTAINMENT HOLDING CORP's revenue compounded faster (32.1% CAGR vs 5.3%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Alliance Atlantis Communications Inc. was a media company that operated primarily as a specialty service provider in Canada. Primarily based in Toronto, Alliance Atlantis also had offices in Halifax, Los Angeles, London, Dublin, Madrid, Barcelona, Shannon, and Sydney.

ACAD vs AENT — Head-to-Head

Bigger by revenue
AENT
AENT
1.4× larger
AENT
$368.7M
$268.1M
ACAD
Growing faster (revenue YoY)
ACAD
ACAD
+16.1% gap
ACAD
9.7%
-6.3%
AENT
Higher net margin
AENT
AENT
1.2% more per $
AENT
2.5%
1.4%
ACAD
Faster 2-yr revenue CAGR
AENT
AENT
Annualised
AENT
32.1%
5.3%
ACAD

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
ACAD
ACAD
AENT
AENT
Revenue
$268.1M
$368.7M
Net Profit
$3.6M
$9.4M
Gross Margin
Operating Margin
-1.7%
4.7%
Net Margin
1.4%
2.5%
Revenue YoY
9.7%
-6.3%
Net Profit YoY
32.8%
EPS (diluted)
$0.02
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
AENT
AENT
Q1 26
$268.1M
Q4 25
$284.0M
$368.7M
Q3 25
$278.6M
$254.0M
Q2 25
$264.6M
$227.8M
Q1 25
$244.3M
$213.0M
Q4 24
$259.6M
$393.7M
Q3 24
$250.4M
$229.0M
Q2 24
$242.0M
$236.9M
Net Profit
ACAD
ACAD
AENT
AENT
Q1 26
$3.6M
Q4 25
$273.6M
$9.4M
Q3 25
$71.8M
$4.9M
Q2 25
$26.7M
$5.8M
Q1 25
$19.0M
$1.9M
Q4 24
$143.7M
$7.1M
Q3 24
$32.8M
$397.0K
Q2 24
$33.4M
$2.5M
Gross Margin
ACAD
ACAD
AENT
AENT
Q1 26
Q4 25
90.8%
Q3 25
92.2%
Q2 25
92.2%
Q1 25
91.7%
Q4 24
91.6%
Q3 24
92.5%
Q2 24
92.5%
Operating Margin
ACAD
ACAD
AENT
AENT
Q1 26
-1.7%
Q4 25
6.1%
4.7%
Q3 25
12.8%
4.2%
Q2 25
12.2%
4.3%
Q1 25
7.9%
1.7%
Q4 24
59.1%
3.8%
Q3 24
12.6%
0.9%
Q2 24
12.6%
0.2%
Net Margin
ACAD
ACAD
AENT
AENT
Q1 26
1.4%
Q4 25
96.3%
2.5%
Q3 25
25.8%
1.9%
Q2 25
10.1%
2.5%
Q1 25
7.8%
0.9%
Q4 24
55.4%
1.8%
Q3 24
13.1%
0.2%
Q2 24
13.8%
1.1%
EPS (diluted)
ACAD
ACAD
AENT
AENT
Q1 26
$0.02
Q4 25
$1.61
$0.18
Q3 25
$0.42
$0.10
Q2 25
$0.16
$0.11
Q1 25
$0.11
$0.04
Q4 24
$0.86
$0.14
Q3 24
$0.20
$0.01
Q2 24
$0.20
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
AENT
AENT
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$117.6M
Total Assets
$1.6B
$434.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
AENT
AENT
Q1 26
Q4 25
$177.7M
Q3 25
$258.0M
Q2 25
$253.6M
Q1 25
$217.7M
Q4 24
$319.6M
Q3 24
$155.1M
$4.3M
Q2 24
$177.1M
$1.1M
Stockholders' Equity
ACAD
ACAD
AENT
AENT
Q1 26
Q4 25
$1.2B
$117.6M
Q3 25
$917.3M
$108.1M
Q2 25
$822.4M
$103.2M
Q1 25
$765.2M
$97.4M
Q4 24
$732.8M
$95.6M
Q3 24
$577.2M
$88.0M
Q2 24
$516.7M
$87.6M
Total Assets
ACAD
ACAD
AENT
AENT
Q1 26
$1.6B
Q4 25
$1.6B
$434.1M
Q3 25
$1.3B
$383.0M
Q2 25
$1.2B
$361.2M
Q1 25
$1.1B
$349.4M
Q4 24
$1.2B
$401.7M
Q3 24
$976.9M
$395.7M
Q2 24
$914.1M
$340.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
AENT
AENT
Operating Cash FlowLast quarter
$-16.5M
Free Cash FlowOCF − Capex
$-16.9M
FCF MarginFCF / Revenue
-4.6%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-1.76×
TTM Free Cash FlowTrailing 4 quarters
$-1.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
AENT
AENT
Q1 26
Q4 25
$-48.7M
$-16.5M
Q3 25
$74.3M
$2.7M
Q2 25
$64.0M
$10.7M
Q1 25
$20.3M
$2.5M
Q4 24
$40.4M
$25.3M
Q3 24
$63.2M
$-11.6M
Q2 24
$25.0M
$9.7M
Free Cash Flow
ACAD
ACAD
AENT
AENT
Q1 26
Q4 25
$-16.9M
Q3 25
$73.9M
$2.4M
Q2 25
$10.7M
Q1 25
$2.4M
Q4 24
Q3 24
$63.2M
$-11.6M
Q2 24
FCF Margin
ACAD
ACAD
AENT
AENT
Q1 26
Q4 25
-4.6%
Q3 25
26.5%
0.9%
Q2 25
4.7%
Q1 25
1.1%
Q4 24
Q3 24
25.2%
-5.1%
Q2 24
Capex Intensity
ACAD
ACAD
AENT
AENT
Q1 26
Q4 25
0.1%
Q3 25
0.1%
0.1%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.0%
0.0%
Q2 24
Cash Conversion
ACAD
ACAD
AENT
AENT
Q1 26
Q4 25
-0.18×
-1.76×
Q3 25
1.03×
0.56×
Q2 25
2.40×
1.86×
Q1 25
1.07×
1.33×
Q4 24
0.28×
3.57×
Q3 24
1.93×
-29.31×
Q2 24
0.75×
3.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons